Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-01

Clinical Trial Update: Helicobacter Eradication Relief of Dyspeptic Symptoms [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Helicobacter pylori eradication for relief of dyspeptic symptoms in functional dyspepsia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Functional Dyspepsia | Phase 3 | Status: COMPLETED